These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2004-003703-21 The role of hyperhomocysteinemia in the genesis of atherothrombotic vascular disease bad-data
Completed, but no date 2005-005290-30 A Non- randomized, Single-Center, Open Label Case Series Study of Intravitreal Triamcinolone Acetate Injections (IVTA) Used as Adjunctive to Verteporfin Photodynamic Therapy (PDT) in the Treatment Pre... bad-data
Completed, but no date 2006-006312-30 A phase IV non-randomized, uncontrolled, open-label, single-center trial to evaluate the safety and efficacy of Macugen (pegaptanib sodium) given by intravitreal injections every 6 weeks in patients w... bad-data
Completed, but no date 2007-000811-27 Evaluation of additional intraocular pressure reduction with once daily, evening administration of travoprost 0.004%, once daily, evening administration of travoprost 0.004%/timolol 0.5% fixed combina... bad-data
Not reported 2008-001128-30 EFFICACY OF SERTINDOLE AS COMPARED TO OLANZAPINE OR RISPERIDONE ON PREATTENTIONAL AND ATTENTION-DEPENDENT FUNCTIONS IN PATIENTS WITH CHRONIC SCHIZOPHRENIA. A COGNITIVE AND FMRI STUDY. 2011-10-19 due-trials
Completed, but no date 2008-002089-74 The investigation of the effect of dihydralazine (Depressan) on macular edema of type 2 diabetes patients and of inhibition of semicarbazide-sensitive amine oxidase (SSAO). bad-data
Not reported 2008-007232-18 Comparison of the effect of intravitreal ranibizumab injections compared to macular grid-pattern laser therapy for the symptomatic treatment of diabetic macular edema (a randomized, controlled, phase ... 2012-03-20 due-trials
Ongoing 2010-023594-18 CPT-SIOP-2009 Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Patients with Choroid Plexus Tumors. CPT-SIOP-2009 Nemzetközi, kezelés optimalizáló vizsgálat plexus ... not-yet-due
Ongoing 2013-000048-24 Randomised clinical trial evaluating the safety and effectiveness of esmolol and metoprolol for heart rate control of patients referred to coronary CT angiography Randomizált klinikai vizsgálat, me... not-yet-due
Ongoing 2014-004268-38 Individual Patient Access to AbbVie ABT-450/ritopnavir/ABT-267 and ABT-333 Coadministeres with ribavirin (RBV) in Adult Liver Transplant Recipient with Genotype 1 Hepatitis C Virus Infection not-yet-due
Ongoing 2016-004193-18 Effect of repetitive levosimendan treatment on clinical outcomes of chronic heart failure patients: focus on optimal patient selection based on novel cardiac biomarkers. Ismételt levosimendan alkal... not-yet-due
Ongoing 2018-004083-62 Effect of preoperative intramasseteric methylprednisolone injection on the post-operative sequelae of lower third molar surgery: a placebo controlled, randomized, double-blinded study Preoperatívan... not-yet-due
Ongoing 2020-001638-37 Comparison of the preventive painkiller effect of etoricoxib and celecoxib after M3M surgery: A randomized, double-masked clinical trial Az etoricoxib és a celecoxib preventív fájdalomcsillapító ha... not-yet-due
Ongoing 2021-001268-58 Investigation of cellbiological effects of cariprazine in patients with mitochondrial schizophrenia A cariprazine sejtbiológiai hatásának vizsgálata mitochondriális dysfunkcióval asszociált schizop... not-yet-due
Ongoing 2021-001665-20 Prospective, randomized, controlled, double-blinded study on the efficacy of nebulized 4.2% sodium-bicarbonate in COVID-19 pneumonia Prospektív, kontrollált, randomizált kettős vak vizsgálat 4,2 %-... not-yet-due
Ongoing 2023-000156-38 Value-based health economic comparative study of subcutaneous and intravenous trastuzumab-pertuzumab for HER-2 positive metastatic breast cancer based on patient reported outcomes. A szubkután és ... not-yet-due
Other 2023-000166-33 Implementation study of lipid management of high-risk cardiovascular patients- Semmelweis Lipid Center for high-risk patients Magas rizikójú kardiovaszkuláris betegek lipid-menedzsmentje- az iránye... not-yet-due